0001140361-13-021688.txt : 20130517
0001140361-13-021688.hdr.sgml : 20130517
20130517172511
ACCESSION NUMBER: 0001140361-13-021688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130515
FILED AS OF DATE: 20130517
DATE AS OF CHANGE: 20130517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KIRK THOMAS F
CENTRAL INDEX KEY: 0001258258
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 13856071
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0306
4
2013-05-15
0
0000722723
HANGER, INC.
HGR
0001258258
KIRK THOMAS F
2616 LIGHTHOUSE BEND DR
PONTE VEDRA BEACH
FL
32082
1
0
0
0
Common Stock
2013-05-15
4
A
0
5525
0
A
478647
D
Common Stock
2013-05-15
4
A
0
1019
32.39
A
479666
D
Common Stock
2013-05-15
4
M
0
100000
15.67
A
579666
D
Common Stock
2013-05-15
4
F
0
69717
32.28
D
509949
D
Option to Buy
15.67
2013-05-15
4
M
0
100000
0
D
2005-01-02
2014-01-02
Common Stock
100000
0
D
Option to Buy
8.08
2006-01-03
2015-01-03
Common Stock
100000
100000
D
Consists of shares of restricted stock granted under the Company's 2010 Omnibus Incentive Plan (the "Plan"), which vest to the extent of one-third on May 15, 2014 and cumulatively vest to the extent of one-third each year thereafter, subject to certain provisions of the Plan.
Consists of shares of restricted stock which the Reporting Person elected to receive in lieu of the annual director fee payable to the Reporting Person.
This option vested over a four-year period from the date of grant and is now fully vested.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas F. Kirk
2013-05-17